NEW RESOURCE: CDC and FDA Recommendation to Pause Use of Johnson & Johnson COVID-19 Vaccine (Talking Points)

Resource Details


Hepatitis C Virus (HCV) Cost Calculator

Resource Topic: Clinical Issues, Value-Based Health Care Transformation, Promising Practice

Keywords: Chronic Diseases and Care, Health Risk and Behavior.

Year Developed: 2020

Resource Type: Toolkit.

Primary Audience: Clinicians
Secondary Audience: C-Suite (CEOs, CFOs, CIO, COOs, CMOs, etc.)

Language: English

Developed by: National Nurse-Led Care Consortium (See other resources developed by this organization).

Resource Summary: NNCC’s HCV Cost Calculator is an interactive tool designed to evaluate the costs and benefits of Standard vs Enhanced HCV Care. The HCV Cost Calculator uses a numerical value-based model of health center staff training, screening, and treatment regimen to estimate the cost-benefit comparison and return on investment (ROI) to the health center.

Resource Details: The HCV Cost Calculator is based off of an evidenced based model piloted at the Public Health Management Corporation Care Clinic in Philadelphia, PA. Throughout the calculator, “Standard Screening” references current risk based CDC screening guidelines including persons born 1945-1965, persons who previously or currently inject drugs, and other associated risk factors. “Universal Screening” references screening patients 18 years and older, regardless of risk factors. “Enhanced” services are those identified as promising practices in the model, including: Medical Assistant (MA) initiated opt-out universal screening, reflex testing, care coordination for prior authorizations, integrated behavioral health consultation, and onsite treatment.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,375,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit